AMANDA SMIDT: Open Payments
NPI 1356699169 · RINGGOLD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,365 in 157 payments from 21 companies in 2025. Trend: 2023 $3,430 · 2024 $5,109 · 2025 $3,365
Food & beverage: $3,159Education: $206
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 15 | $502 |
| Regeneron Healthcare Solutions, Inc. | 17 | $381 |
| Galderma Laboratories, L.P. | 14 | $351 |
| Novartis Pharmaceuticals Corporation | 18 | $303 |
| UCB, Inc. | 10 | $289 |
| Lilly USA, LLC | 10 | $250 |
| ABBVIE INC. | 17 | $227 |
| E.R. Squibb & Sons, L.L.C. | 11 | $192 |
| Janssen Biotech, Inc. | 16 | $176 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $171 |
Products named: DUPIXENT, NEMLUVIO, Bimzelx, EBGLYSS, COSENTYX, LIBTAYO, Sotyktu, TREMFYA.
Industry payments across GA — which companies pay providers there.
